PL1761785T3 - Sposób diagnozowania Lawsonia intracellulari - Google Patents

Sposób diagnozowania Lawsonia intracellulari

Info

Publication number
PL1761785T3
PL1761785T3 PL05755345T PL05755345T PL1761785T3 PL 1761785 T3 PL1761785 T3 PL 1761785T3 PL 05755345 T PL05755345 T PL 05755345T PL 05755345 T PL05755345 T PL 05755345T PL 1761785 T3 PL1761785 T3 PL 1761785T3
Authority
PL
Poland
Prior art keywords
lawsonia intracellularis
diagnosing lawsonia
diagnosing
intracellularis
lawsonia
Prior art date
Application number
PL05755345T
Other languages
English (en)
Polish (pl)
Inventor
Malik Merza
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04014804A external-priority patent/EP1609870A1/en
Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh
Publication of PL1761785T3 publication Critical patent/PL1761785T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56922—Campylobacter
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PL05755345T 2004-06-24 2005-06-23 Sposób diagnozowania Lawsonia intracellulari PL1761785T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP04014804A EP1609870A1 (en) 2004-06-24 2004-06-24 Method of diagnosing lawsonia intracellularis
EP04027193 2004-11-16
EP05755345A EP1761785B1 (en) 2004-06-24 2005-06-23 Method of diagnosing lawsonia intracellularis
PCT/EP2005/006781 WO2006012949A1 (en) 2004-06-24 2005-06-23 Method of diagnosing lawsonia intracellularis

Publications (1)

Publication Number Publication Date
PL1761785T3 true PL1761785T3 (pl) 2011-02-28

Family

ID=34971368

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05755345T PL1761785T3 (pl) 2004-06-24 2005-06-23 Sposób diagnozowania Lawsonia intracellulari

Country Status (21)

Country Link
US (12) US7303891B2 (cg-RX-API-DMAC10.html)
EP (1) EP1761785B1 (cg-RX-API-DMAC10.html)
JP (1) JP2008503737A (cg-RX-API-DMAC10.html)
KR (2) KR101389302B1 (cg-RX-API-DMAC10.html)
CN (1) CN1973205B (cg-RX-API-DMAC10.html)
AR (1) AR049411A1 (cg-RX-API-DMAC10.html)
AT (1) ATE479100T1 (cg-RX-API-DMAC10.html)
AU (1) AU2005269043B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI0512546B1 (cg-RX-API-DMAC10.html)
CA (1) CA2568821C (cg-RX-API-DMAC10.html)
CY (1) CY1110948T1 (cg-RX-API-DMAC10.html)
DE (1) DE602005023157D1 (cg-RX-API-DMAC10.html)
DK (1) DK1761785T3 (cg-RX-API-DMAC10.html)
MX (1) MXPA06015207A (cg-RX-API-DMAC10.html)
MY (1) MY146476A (cg-RX-API-DMAC10.html)
PL (1) PL1761785T3 (cg-RX-API-DMAC10.html)
PT (1) PT1761785E (cg-RX-API-DMAC10.html)
RU (1) RU2400758C2 (cg-RX-API-DMAC10.html)
SI (1) SI1761785T1 (cg-RX-API-DMAC10.html)
TW (1) TW200617174A (cg-RX-API-DMAC10.html)
WO (1) WO2006012949A1 (cg-RX-API-DMAC10.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY146476A (en) * 2004-06-24 2012-08-15 Boehringer Ingelheim Vetmed Method of diagnosing lawsonia intracellularis
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US8398994B2 (en) 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
US20080241190A1 (en) * 2006-11-13 2008-10-02 Boehringer Ingelheim Vetmedica, Inc. Vaccination of horses against lawsonia intracellularis
WO2008073464A2 (en) 2006-12-11 2008-06-19 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
US8398970B2 (en) * 2007-09-17 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Method of preventing early Lawsonia intracellularis infections
US10125388B2 (en) 2007-10-31 2018-11-13 Akonni Biosystems, Inc. Integrated sample processing system
JP5723772B2 (ja) 2008-07-22 2015-05-27 インターベット インターナショナル ベー. フェー. 新規血清型のローソニア・イントラセルラリス細菌、その細菌に基づくワクチン、該新規ローソニア・イントラセルラリス血清型の特定に適した抗体および該抗体を製造するためのハイブリドーマ
US8518658B1 (en) * 2009-04-27 2013-08-27 University Of South Florida ATP-bioluminescence immunoassay
CA3041540C (en) * 2009-09-21 2021-08-24 Bio-Rad Laboratories, Inc. Magnetic lysis method and device
EP2523434A1 (en) 2011-05-11 2012-11-14 10n2 Technologies, Inc. A method for limiting the use of a mobile communications device dependent on the travelling speed
CN103698514B (zh) * 2013-12-17 2015-11-18 广西大学 检测猪胞内劳森氏菌抗体的elisa试剂盒
WO2024260953A1 (en) * 2023-06-23 2024-12-26 Intervet International B.V. A method of culturing lawsonia intracellularis bacteria
CN119044482B (zh) * 2024-08-08 2025-11-18 华中农业大学 一种检测胞内劳森菌抗体的阻断elisa试剂盒和方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130232A (en) * 1990-06-12 1992-07-14 The United States Of America As Represented By The Secretary Of Agriculture Monoclonal antibody immunoassay kit for avian reticuloendotheliosis virus
JP3547022B2 (ja) * 1994-12-16 2004-07-28 富士写真フイルム株式会社 磁気記録媒体
US5885823A (en) 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
US5714375A (en) 1995-06-05 1998-02-03 Nobl Laboratories, Inc. Ileal symbiont intracellularis propagation in suspended host cells
JP2000502054A (ja) * 1995-11-30 2000-02-22 アグリカルチャー ビクトリア サービシーズ ピーティーワイ.エルティーディー. 治療用および診断用の組成物
EP0974660A1 (en) 1998-06-19 2000-01-26 Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) Newcastle disease virus infectious clones, vaccines and diagnostic assays
CN1260492A (zh) * 1999-11-09 2000-07-19 赵永同 肿瘤预后评估试剂盒及其制备工艺
WO2002026250A2 (en) 2000-09-29 2002-04-04 Arizona Board Of Regents On Behalf Of The University Of Arizona Vaccines for proliferative ileitis
EP1219711B1 (en) * 2000-12-20 2006-06-14 Intervet International BV Lawsonia intracellularis vaccine
JP4079727B2 (ja) 2002-09-06 2008-04-23 セントラル硝子株式会社 光学活性1−(フルオロ、トリフルオロメチルまたはトリフルオロメトキシ置換フェニル)アルキルアミンn−モノアルキル誘導体とその製造方法
WO2004033631A2 (en) 2002-10-04 2004-04-22 Regents Of The University Of Minnesota Nucleic acid and polypeptide sequences from lawsonia intracellularis and methods of using
EP1709067B1 (en) 2004-01-22 2010-06-09 Intervet International BV Lawsonia intracellularis subunit vaccines
MY146476A (en) * 2004-06-24 2012-08-15 Boehringer Ingelheim Vetmed Method of diagnosing lawsonia intracellularis

Also Published As

Publication number Publication date
RU2007102426A (ru) 2008-07-27
RU2400758C2 (ru) 2010-09-27
US8021663B2 (en) 2011-09-20
US7799562B2 (en) 2010-09-21
US20110201786A1 (en) 2011-08-18
US20110201788A1 (en) 2011-08-18
DK1761785T3 (da) 2010-11-08
KR20070026855A (ko) 2007-03-08
KR101306610B1 (ko) 2013-09-11
CA2568821C (en) 2017-02-14
KR20130012085A (ko) 2013-01-31
AU2005269043A1 (en) 2006-02-09
ATE479100T1 (de) 2010-09-15
AU2005269043B2 (en) 2011-10-27
US8007802B1 (en) 2011-08-30
US8114666B2 (en) 2012-02-14
AR049411A1 (es) 2006-07-26
US8007801B1 (en) 2011-08-30
JP2008503737A (ja) 2008-02-07
US20070003991A1 (en) 2007-01-04
DE602005023157D1 (de) 2010-10-07
US7303891B2 (en) 2007-12-04
US20110275147A1 (en) 2011-11-10
SI1761785T1 (sl) 2010-12-31
US20110275148A1 (en) 2011-11-10
US8003107B1 (en) 2011-08-23
CA2568821A1 (en) 2006-02-09
US20110033870A1 (en) 2011-02-10
TW200617174A (en) 2006-06-01
EP1761785A1 (en) 2007-03-14
PT1761785E (pt) 2010-11-10
EP1761785B1 (en) 2010-08-25
US7635590B2 (en) 2009-12-22
US20100112608A1 (en) 2010-05-06
US7960174B2 (en) 2011-06-14
US20110275149A1 (en) 2011-11-10
US20110201789A1 (en) 2011-08-18
WO2006012949A1 (en) 2006-02-09
CY1110948T1 (el) 2015-06-10
US8114667B2 (en) 2012-02-14
MXPA06015207A (es) 2007-03-26
US20110201787A1 (en) 2011-08-18
US20110201790A1 (en) 2011-08-18
MY146476A (en) 2012-08-15
BRPI0512546B1 (pt) 2016-07-19
CN1973205B (zh) 2012-07-18
US20080102479A1 (en) 2008-05-01
CN1973205A (zh) 2007-05-30
KR101389302B1 (ko) 2014-04-25
US8058062B1 (en) 2011-11-15
BRPI0512546A (pt) 2008-03-25
US7993649B1 (en) 2011-08-09

Similar Documents

Publication Publication Date Title
GB0401730D0 (en) Diagnosis method
ZA200707799B (en) Immunogenic compositions comprising lawsonia intracellularis
ZA200800123B (en) Method for diagnosing multiple sclerosis
EP1876030A4 (en) METHOD FOR PRODUCING A BROCHURE BRUSH AND KIT FOR PRODUCING A BROCHURE BRUSH
DK1761785T3 (da) Fremgangsmåde til diagnosticering af Lawsonia intracellularis
GB0406271D0 (en) Diagnostic test
GB2418521B (en) Endoscopy training simulator
GB0411198D0 (en) Genotoxic testing
ZA200609636B (en) Method of diagnosing lawsonia intracellularis
GB2420416B (en) Sliding mode method for predictive diagnostics
GB0330154D0 (en) NMR leak test
GB0316539D0 (en) Compound testing method
GB0408684D0 (en) Diagnostic method
EP2102228A4 (en) METHOD FOR DIAGNOSIS OF PREECLAMPSIA
GB0427827D0 (en) Method of diagnosis
GB2433320B (en) Diagnostic method
GB0324255D0 (en) Diagnostic method
GB0408685D0 (en) Diagnostic method
GB0421258D0 (en) Diagnostic method
GB0413915D0 (en) Diagnostic method
GB0413914D0 (en) Diagnostic method
GB0413918D0 (en) Diagnostic method
GB0421257D0 (en) Diagnostic method
GB0413916D0 (en) Diagnostic method
GB0400607D0 (en) Diagnostic method